Delta-like SARS-CoV-2 Variants are Most Likely to Increase Pandemic Severity: Study

A SARS-CoV-2 variant with traits similar to that of the Delta variant with enhanced transmissibility can cause a more severe pandemic with more infections.

A SARS-CoV-2 variant with traits similar to that of the Delta variant with enhanced transmissibility and the ability to infect people who had previous infections can cause a more severe pandemic with more infections, revealed a mathematical model created by researchers at Harvard T.H. Chan School of Public Health.

Their work, which was published online in Cell, could help researchers and public health officials interpret the significance of novel and existing variants and design tailored public health responses for various scenarios based on a variant’s characteristics.

Emerging Dangerous COVID-19 Variants
Biologists have warned that relaxing COVID-19 restrictions when large numbers of individuals remain unvaccinated is inherently risky.

‘As the COVID pandemic has progressed, variants of the initial wild-type SARS-CoV-2 virus have emerged.’

“Thus far, evidence of immune escape—the ability of a variant to evade the immune system and cause reinfections or breakthrough infections—has been a red flag,” said Mary Bushman, co-author of the Cell paper and a postdoctoral research fellow in the Department of Epidemiology at Harvard Chan School. “Our findings say it’s maybe more of a yellow flag—this is not such a big deal on its own. But when it’s combined with enhanced transmissibility, then it can be a really big deal.”

Some have quickly become a dominant strain and increased the number of infections, like the Alpha and Delta variants, while others, like Beta, failed to take hold or significantly affect the pandemic’s trajectory. To understand the effects that certain factors would have on a pandemic, Bushman created a model that simulates how pandemics fueled by hypothetical variants would affect populations that are using various combinations of masking with physical distancing, and vaccinations.

The analysis simulated a SARS-CoV-2 pandemic with several different hypothetical variants including combinations of the two traits: enhanced transmissibility, similar to the Alpha variant; partial immune escape, similar to the Beta variant; enhanced transmissibility with partial immune escape, similar to the Delta variant; and a variant with neither trait. The analysis also factored in how certain variables, such as masking/physical distancing or vaccinations, would affect the pandemic’s trajectory. For each of the scenarios, the researchers analyzed the total number of infections as well as the number/percentage of infections averted by vaccination.

Role of T Cells in Fight Against COVID-19 Variants
T cell response through COVID-19 vaccines makes the immune system to recognize these new variants and stop severe COVID-19 infection.

Bushman and their team determined that a variant with enhanced transmissibility alone would likely be more dangerous than a variant that could partially evade the immune system. Yet a variant with both traits could cause more infections, reinfections, and breakthrough infections than a variant with either trait alone.

According to the model, vaccination is also predicted to be highly beneficial in the case of Delta-like variants because vaccinations would prevent a greater number of cases that a more transmissible virus would potentially cause, and because the milder nature of breakthrough infections should substantially reduce overall mortality.

WHO Named COVID-19 Variants of India as 'Delta' and 'Kappa'
COVID-19 variant first found in India will now be called as Delta while earlier found variant in the country will be known as Kappa , says the WHO.

“It’s really important that people realize the emergence of variants like Delta make high levels of vaccination all the more crucial,” said Bill Hanage, associate professor of epidemiology and co-author of the Cell paper. “Even if we cannot eliminate the virus, we can ensure that people face it with the best preparation, and a more transmissible virus means there will be more infections in the absence of vaccination, so more people stand to benefit from it.”

Other Harvard Chan School co-authors of the study included Rebecca Kahn, Bradford Taylor, and Marc Lipsitch.

Covaxin Offers Protection Against New COVID-19 Variants
Bharat Biotech's Covaxin demonstrates protection against the new Covid-19 variants, says new study. A modest reduction in neutralisation was observed against B1617 variant compared to vaccine variant.

This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI128344), U.S. National Cancer Institute SeroNet (U01CA261277), and the U.S. Centers for Disease Control and Prevention (200-2016-91779).

“Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape,” Mary Bushman, Rebecca Kahn, Bradford P. Taylor, Marc Lipsitch, William P. Hanage, Cell, online November 19, 2021, doi: 10.1016/j.cell.2021.11.026

Visit the Harvard Chan School website for the latest news, press releases, and multimedia offerings.

Source-Eurekalert